Head-to-head · Cost-Efficiency Index
Emerge Weight Loss vs NovoCare Pharmacy
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Emerge Weight Loss
Shoppers who specifically want tirzepatide with per-dose-tier pricing shown up front, not semaglutide.
Visit Emerge Weight LossNovoCare Pharmacy
Patients who already have a Wegovy prescription and want the lowest-cost manufacturer-direct self-pay or insurance-copay price — not a fit for readers still looking for a prescriber.
Visit NovoCare PharmacyThe verdict
Emerge Weight Loss and NovoCare Pharmacy tie on the Cost-Efficiency Index at 57/100, so neither wins outright on the numbers. For most shoppers we'd start with Emerge Weight Loss (ranked #303, a hair above #309) — Shoppers who specifically want tirzepatide with per-dose-tier pricing shown up front, not semaglutide. But NovoCare Pharmacy is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Emerge Weight Loss.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Emerge Weight Loss | NovoCare Pharmacy |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 57/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | $224/mo (2.5 mg dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | $2,688 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #303 | #309 |
Emerge Weight Loss
57/100Where the value is
- Publishes an actual per-dose price ladder ($224-$289 across five tiers) rather than a single vague 'starting at' figure
- No signup fee and no separate doctor fee — the FAQ states syringes, overnight shipping and medical oversight are bundled into the quoted price
- No minimum commitment; cancel anytime with only a $10 processing fee if an order hasn't shipped yet
The tradeoffs
- No semaglutide product at all — Emerge is tirzepatide-only, so it's not an option for patients who specifically want or are already on semaglutide
- The 'Maintenance Plans from $49 per 4 weeks' line is misleading on its own — refills actually cost $99/vial, so $49 is a floor, not the real recurring price
NovoCare Pharmacy
57/100Where the value is
- First-party Novo Nordisk program — the most authoritative source for actual Wegovy self-pay and insurance-copay pricing, with no telehealth-platform markup
- Commercially-insured patients can pay as little as $25/month, capped at $100/month in savings
- New oral 'Wegovy Pill' option now available from $149/month, in addition to the injectable pen
The tradeoffs
- This is NOT a telehealth or prescribing service — it requires a valid Wegovy prescription obtained elsewhere, with no consultation or clinical support included
- Introductory pricing is time-limited: the $199/month pen offer expires 12/31/2026 (reverting to $349/month) and the 4mg pill price updates 8/31/2026
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.